|

Cevostamab Clinical Trials

7 actively recruiting trials across 2 locations

▲ +2 trials since August 2026

Also known as: BFCR4350A, RO7187797

Pipeline

Phase 1: 4Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Hoffmann-La Roche3
  • Genentech, Inc.3
  • Regeneron Pharmaceuticals1

Indications

  • Cancer6
  • Multiple Myeloma5
  • Lupus Erythematosus, Systemic1
  • Relapsed or Refractory Multiple Myeloma1
  • Lupus1

Other4 trials

A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
Phase 1/2
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Phase 1
Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple Myeloma
Phase 2
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Phase 1

Duarte, California2 trials

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

City of Hope

Phase 1
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

City of Hope National Medical Center

Phase 3

La Jolla, California1 trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Scripps Clinic Torrey Pines

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.